Chang Liu

Chang Liu has a diverse work experience in the fields of strategic insights, market research, and management consulting. Chang is currently serving as the Director of Global Strategic Insights at Sobi - Swedish Orphan Biovitrum AB (publ), a position they have held since 2023. Prior to this role, they worked as an Associate Director of Strategic Insight at the same company from 2022 to 2023. From 2020 to 2022, Chang served as the Global Market Insights Manager in the Hematology division at Sobi.

Before joining Sobi, Chang worked as a Management Consultant at IQVIA from 2018 to 2020, where they gained expertise in strategic planning and business consulting. Chang also pursued academic research as a Postdoctoral Fellow at Karolinska University Hospital from 2016 to 2018, focusing on an undisclosed discipline. As a Visiting Scholar at Penn State University in 2015, Chang Liu further deepened their knowledge in their field of study.

Chang Liu obtained a Bachelor's degree in biology from Nankai University in 2010. Following this, Liu pursued a Master's degree in biomedicine at Karolinska Institutet, which was completed in 2012. Continuing the academic journey, Liu then achieved a Doctor of Philosophy (Ph.D.) degree in Exercise Physiology with a focus on Cellular Growth from Karolinska Institutet in 2016.